NCT00546234|WithdrawnPhase 4
Study Stopped
No subjects enrolled and no ongoing funding.
Tiotropium for Smoking Asthmatics Study
Assessing Treatment Options for Smokers With Asthma.
Loading search results
Sponsor study identifier
interventional
0
1 country
2
Study Start
November 2007
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
January 2014
Actual (reported)Study Completion
January 2014
Actual (reported)The study's research questions concern the appropriateness of use of tiotropium for patients with asthma who are current smokers. It is suggested that patients with asthma who smoke, may in fact share similarities with patients with chronic obstructive pulmonary disease (COPD). Because of this, the study will determine whether this sub-group of patients would in fact benefit from therapy currently approved and marketed for COPD patients.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
January 2014
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
October 16, 2007
Actual (reported)October 18, 2007
Actual (reported)November 2007
Date type not reportedThis date has not been verified as actual or estimated.
January 2014
Actual (reported)January 2014
Actual (reported)To evaluate whether current smokers with asthma benefit from the introduction of tiotropium.
10 weeks
To assess whether there are specific genotypes that identify specific asthma patient populations that may benefit from this therapy.
10 weeks
To determine if the Virtual Asthma Clinic is an acceptable tool for data collection in a clinical trial setting.
10 weeks
18 mcg daily via Handihaler
Turbohaler, 6 \& 12 mcg
University of Alberta Hospital
Edmonton, Alberta, Canada
Royal University Hospital
Saskatoon, Saskatchewan, Canada
Irvin Mayers, MD, FRCPC
University of Alberta
Darcy Marciniuk, MD
University of Saskatchewan
Dilini Vethanayagam, MD
University of Alberta
Harissios Vliagoftis, MD
Unviersity of Alberta
0 participants (actual enrollment reported by the registry).
First Submitted
October 16, 2007
First Posted
October 18, 2007
Study Start
November 2007
Date type not reportedThis date has not been verified as actual or estimated.
Asthma Care With Alvesco® (Ciclesonide) in Primary Care in Adults - The ACCEPT-study (BY9010/CA-102)
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Primary Completion
January 2014
Actual (reported)Study Completion
January 2014
Actual (reported)Last Updated
May 26, 2016
Record last verified: 2014-08
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: